by Robert Neil
Health Care Trends: Payment Bundling--The Future of Reimbursement?
A number of industry experts have long believed that any significant change in health care must be tied to reimbursement, and the Centers for Medicare and Medicaid Services (CMS) has begun a pilot project that will test that theory. Under a three-year plan called the Acute Care Episode (ACE) demonstration, five sites in the US have been selected to use a single, bundled-payment system for hospital and physicians services associated with 28 cardiac and nine orthopedic inpatient surgical services and procedures.
More from Policy & Regulation
• By
Medical devices, diagnostics, and equipment face tariffs announced by President Donald Trump, despite industry pleas for exemption. The tariffs, ranging from 10%-49%, impact most countries trading with the US, potentially hindering innovation and increasing costs in the medtech sector.
• By
The US FDA has published its final document to guide sponsors on using sex-specific data in designing clinical trials of medical devices. However, the guidance removes all references to gender that appeared in January’s draft guidance, released before the Trump administration took office.
• By
Calley Means defended reductions in force at the Health and Human Services Department that shocked and outraged federal workers and stakeholders.
• By
Some employees were not impressed with FDA Commissioner Martin Makary's first speech to the agency staff, saying he did not seem to understand the agency's mission.
More from Medtech Insight
• By
Swiss medtech exporters seek urgent diplomatic action from the Swiss Federal Council in a bid to overturn the 2 April US decision to put tariffs on goods imports.
• By
Beyond the US market, Monogram is actively pursuing regulatory approvals abroad, with India as a key target. The company has partnered with Shalby Hospitals, one of India’s largest orthopedic hospital networks, to conduct clinical trials and accelerate regulatory clearance in the region.
